Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
16,164,902
-
Share change
-
+16,164,902
-
Total reported value
-
$463,124,000
-
Price per share
-
$28.65
-
Number of holders
-
49
-
Value change
-
+$463,124,002
-
Number of buys
-
49
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q3 2018
As of 30 Sep 2018 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,164,902 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Vanguard Group Inc, and Artal Group S.A..
This table shows 49 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.